Less than others: Abilify (aripiprazole) is an antipsychotic medication. It is an approved adjunctive treatment for major depressive disorder. Extended duration use of all antipsychotics can lead to diabetes; however, the risk is relatively lower with Abilify (aripiprazole) as compared to most of the newer antipsychotics. There are many other alternative adjunctive agents that do not carry risk of diabetes.
Answered 9/29/2016
4.2k views
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question